港股异动丨科济药业-B(02171.HK)涨超4% CT0596已获得国家药监局的IND批准用于治疗R/R MM患者

智通财经
Aug 04
【港股异动丨科济药业-B(02171.HK)涨超4% CT0596已获得国家药监局的IND批准用于治疗R/R MM患者】智通财经APP获悉,科济药业-B(02171.HK)涨超4%,截至发稿,涨4.53%,报13.39港元,成交额819.68万港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10